Literature DB >> 12479977

Longitudinal study of tryptophan degradation during and after pregnancy.

Katharina Schröcksnadel1, Bernhard Widner, Anton Bergant, Gabriele Neurauter, Harald Schennach, Hans Schröcksnadel, Dietmar Fuchs.   

Abstract

In mice, activation of indoleamine-2,3-dioxygenase (IDO), an enzyme converting tryptophan to N-formyl-kynurenine, was found to be necessary requirement to achieve immunotolerance against the fetus and thus uncomplicated pregnancy. In plasma from 20 healthy pregnant women with singleton pregnancies we consecutively analyzed kynurenine and tryptophan concentrations during pregnancy (1 specimen at each trimester of gestation) and postpartum (week 6). None of the women had any signs of infection at the time of plasma sampling, but the study population was otherwise unselected. The kynurenine to tryptophan ratio (kyn/trp) was calculated as an estimate of IDO activity, and data were compared to concentrations of neopterin and 55kD soluble tumor necrosis factor receptor (sTNF-R55), two indicators of immune activation, and to alanineaminotransferase (ALT) levels. Increasing kynurenine and decreasing tryptophan concentrations were found during pregnancy, data suggesting significant degradation of tryptophan. In parallel, increasing concentrations of immune activation markers neopterin and sTNF-R55 were observed, correlating significantly to kyn/trp. The data point to an involvement of cytokine-induced IDO activation in the degradation of tryptophan observed during pregnancy. After pregnancy, sTNF-R55 and also neopterin concentrations declined, whereas tryptophan concentrations increased, indicating that immune activation and activation-induced tryptophan degradation returned to baseline. By contrast, still increased kynurenine concentrations and also increased kyn/trp point to continuing catabolism of tryptophan. Postpartum elevation of liver enzyme ALT may suggest that increased activity of hepatic tryptophan pyrrolase could be involved in increased conversion of tryptophan despite low degree of immune activation. We conclude that IDO is activated in pregnancy and that the decrease of tryptophan might be related to immune activation phenomena. Sustained increase of kynurenine postpartum seems independent from immune activation process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12479977     DOI: 10.1016/s0024-3205(02)02304-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  23 in total

1.  Maternal tryptophan and kynurenine pathway metabolites and risk of preeclampsia.

Authors:  Roy M Nilsen; Anne-Lise Bjørke-Monsen; Oivind Midttun; Ottar Nygård; Eva R Pedersen; Arve Ulvik; Per Magnus; Håkon K Gjessing; Stein Emil Vollset; Per Magne Ueland
Journal:  Obstet Gynecol       Date:  2012-06       Impact factor: 7.661

Review 2.  Inflammation-associated depression: from serotonin to kynurenine.

Authors:  Robert Dantzer; Jason C O'Connor; Marcus A Lawson; Keith W Kelley
Journal:  Psychoneuroendocrinology       Date:  2010-10-30       Impact factor: 4.905

Review 3.  The role of tryptophan metabolism in postpartum depression.

Authors:  Kai-Ming Duan; Jia-Hui Ma; Sai-Ying Wang; ZhengDong Huang; YingYong Zhou; HeYa Yu
Journal:  Metab Brain Dis       Date:  2018-01-06       Impact factor: 3.584

4.  Restraint Stress during Pregnancy Rapidly Raises Kynurenic Acid Levels in Mouse Placenta and Fetal Brain.

Authors:  Francesca M Notarangelo; Robert Schwarcz
Journal:  Dev Neurosci       Date:  2017-02-18       Impact factor: 2.984

5.  Total sleep time and kynurenine metabolism associated with mood symptom severity in bipolar disorder.

Authors:  Dahlia Mukherjee; Venkatesh Bassapa Krishnamurthy; Caitlin E Millett; Aubrey Reider; Adem Can; Maureen Groer; Dietmar Fuchs; Teodor T Postolache; Erika F H Saunders
Journal:  Bipolar Disord       Date:  2017-08-23       Impact factor: 6.744

6.  Kynurenine pathway metabolites in humans: disease and healthy States.

Authors:  Yiquan Chen; Gilles J Guillemin
Journal:  Int J Tryptophan Res       Date:  2009-01-08

7.  The Kynurenine Pathway of Tryptophan Catabolism and AIDS-Associated Kaposi Sarcoma in Africa.

Authors:  Helen Byakwaga; Peter W Hunt; Miriam Laker-Oketta; David V Glidden; Yong Huang; Bosco M Bwana; A Rain Mocello; John Bennett; Victoria Walusansa; Sheila C Dollard; David R Bangsberg; Edward K Mbidde; Jeffrey N Martin
Journal:  J Acquir Immune Defic Syndr       Date:  2015-11-01       Impact factor: 3.731

Review 8.  Kynurenines, Gender and Neuroinflammation; Showcase Schizophrenia.

Authors:  J de Bie; C K Lim; G J Guillemin
Journal:  Neurotox Res       Date:  2016-06-24       Impact factor: 3.911

9.  Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset.

Authors:  David A Somerset; Yong Zheng; Mark D Kilby; David M Sansom; Mark T Drayson
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

10.  Maternal plasma total neopterin and kynurenine/tryptophan levels during pregnancy in relation to asthma development in the offspring.

Authors:  Maria C Magnus; Øystein Karlstad; Øivind Midtun; Siri E Håberg; Gro Tunheim; Christine L Parr; Per Nafstad; Stephanie J London; Roy M Nilsen; Per M Ueland; Wenche Nystad
Journal:  J Allergy Clin Immunol       Date:  2016-04-20       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.